Abuse Resistant Opioid Laws and their upcoming impact on

New Post Public Reply Private Reply Replies (1) Message Board

Dec 20, 2012 at 8:40 AM

Abuse Resistant Opioid Laws and their upcoming impact on ELTP
If you look at the laws related to abuse resistant opioids and their cumulative effect from 1970-2012 (Present day) you realize passing the next wave of bills such as the STOPP ACT is just the next wave of laws coming.
http://bono.house.gov/news/documentprint.aspx...tID=303838
https://www.popvox.com/bills/us/112/hr6160

http://www.cdc.gov/homeandrecreationalsafety/...index.html
Timeline of Law Enactment
Over the past two decades, the number of states having one or more laws aimed at reducing prescription drug misuse, abuse, and overdose has increased. Lawmaking in this area has steadily accelerated along with growing awareness of prescription drug abuse.
1970s: A few states enacted laws requiring physical examinations of patients before prescribing and imposing prescription limits.

1980s: More states enacted physical examination and prescription limit laws, while a few states began to require identification when picking up prescriptions for controlled substances, and others enacted laws to prohibit doctor shopping.

1990s: Laws were passed in multiple categories, especially physical exam laws, which were enacted by an additional eight states.

2000s: Half of US states adopted tamper-resistant prescription form laws, which was prompted by the passage of federal tamper-resistant form legislation in 2007. During this same decade, a small number of states introduced pain clinic laws and laws that provided immunity or mitigation at sentencing for individuals obtaining medical assistance during an overdose.

AND with Government and Federal pressure placing an emphasis on curtailing the prescription abuse epidemic...it is only a matter of time before a few select Pharma companies will benefit from this pressure and mandates happening daily.
1) The White House has an agenda to curb the epidemic that is prescription drug abuse....
http://www.whitehouse.gov/sites/default/files...e_plan.pdf
Prescription drug abuse is the Nation’s fastest-growing drug problem. While there has been a marked decrease in the use of some illegal drugs like cocaine, data from the National Survey on Drug Use and Health (NSDUH) show that nearly one-third of people aged 12 and over who used drugs for the first time in 2009 began by using a prescription drug non-medically.

2) The House of Representatives recently passed a bill that gives additional funding to the FDA to offset drug shortages....
http://www.reuters.com/article/2012/05/30/us-...LQ20120530
The main purpose of the bill is to reauthorize fees from makers of drugs and devices that help speed FDA evaluation of new medical products. These so-called "user fees" could make up nearly half of the FDA's proposed $4.5 billion budget next year, according to a plan from President Barack Obama.
~~As we know Naltrexone is one of those drugs on various drug shortage lists!
http://www.ashp.org/DrugShortages/Current/bul...spx?id=873

3) The Supreme Court upheld the constitutionality of Obama's Health Care Plan....meaning that everyone will be required to have health care. This, though controversial, will unsure that less money will be spent on the poor and indigent population that uses a disproportionate amount of prescription related opioid abuse funds.
http://www.voanews.com/content/breaking-news-...64278.html

http://www.kentucky.com/2012/02/23/2081181/ho...aging.html
Measure backs use of tamper-resistant pills

A bill approved recently would encourage use of tamper-resistant pain medication in Kentucky as a way to combat the state's crippling level of prescription-drug abuse.

The House Health and Welfare committee voted 13-0 to approve House Bill 377.

Elite Pharmaceuticals Inc (ELTP) Stock Research Links

ELTP Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SPECS Framework: Rethinking Career Growth Strategies

An Evolving Workplace Demands Evolving Strategies Look, careers ain't what they used to be—and they shouldn't be. Today’s world is flipping the script on how we work, and Dr. Brandi R. Muñoz is rewriting the book on career development with her SPECS framework. The guy clinging to his outdated Rolodex for advice isn't gonna cut it anymore. "Who Are Your SPECS?...

Bird-X Welcomes Doolittle to Elevate Sales Strategy

Change in Flight: Bird-X Eyes Strategic Growth Well, here's one that might spread its wings wide. Emanuel Doolittle has joined Bird-X, Inc. as Director of Sales and Business Development. Now, let's not beat around the bush — Bird-X isn't a name you'd see thrown around daily stock talks, but it's stirring up interest in the pest control sector without question. Why...

Goodal Skincare Capitalizes on K-Beauty Craze at Costco

A Venture into American Retail Goodal, the darling of Korea's skincare scene, is staking its claim at Costco. This is no small feat, my friends. We're talkin' about a brand that's carved out a sweet niche with its Green Tangerine line. Now it's hitching its wagon to one of America's retail behemoths, known for its unique knack in beauty products. From Olive Young to...

DUPR Teams Up with InBody to Elevate Pickleball Fitness

Well, here's a twist in the pickleball world—DUPR and InBody have struck a deal to bring top-notch body composition tech to the ever-expanding universe of pickleballers. They're merging power players from two different worlds to tap into your performance on the court and your wellness off it. Maybe I'm just jaded from too many marketing pitches, but this one could...

PG&E's $2B Delay: A Blame Game or Real Crisis?

Just when you think the circus of energy utilities couldn't get any more outlandish, PG&E grabs the spotlight once more. Picture this: they've got the megaphone out, threatening to put the brakes on $2 billion in crucial infrastructure investments. Twenty-five thousand customers left hanging, just waiting for their lights to come on. As if that's not enough, PG&E is also...

Telemed Sites Need Solid Payment Systems with AI

Brace for Impact: Payment Processors in Telehealth A new era is brewing in telehealth, with AI coding tools making website creation a breeze for healthcare folks. But here's the kicker: accepting credit cards is not as easy as setting up a snazzy booking page. Take it from Organic Payment Gateways in good ol' Scarborough, Maine, who've decided to toss their hat into this...

Luxury Vinyl Tiles Market Set for Steady Growth to 2031

Luxury Vinyl Tiles: A Market on the Rise Well, folks, the flooring game is picking up steam, and luxury vinyl tiles (LVT) are in the spotlight. With consumers and businesses all looking for something durable yet easy on the eyes and wallet, LVT is answering the call. MarketsandMarkets™ reports that this sector is expected to balloon from USD 18.22 billion in 2026 to USD...

Bright Minds in Hot Water: Investigation Shakes Investors

FDA Throws Wrench Into Bright Minds' Plans This ain't the first time a biotech company's dream has hit the skids, but Bright Minds Biosciences (NASDAQ:DRUG) found themselves in the meat grinder when the FDA threw their epilepsy trial plans under the bus. The partial clinical hold wasn't a gentle slap on the wrist, but a gut punch driven by mouse toxicity findings and...

ESAC Redefines Entertainment Centers, Eyes 2027 Trends

A New Era for Family Entertainment Centers Forget the traditional FEC with its solitary rides; the future's all about constructing social destinations that blend immersive storytelling and hybrid offerings. Elephant Sculpture Art Co., Ltd. (ESAC) is at the forefront, drawing from their Shanghai WUNPARK project to reimagine the design of these amusement hubs. Set to engage...

AMETEK Surpasses Q3 2026 Expectations, Raises Outlook

A Banner Quarter for AMETEK Holy smokes, AMETEK has thrown down some numbers for the third quarter of 2026 that would make any seasoned trader sit up and take notice. We’re talking record-breaking across the board: $2.22 billion in sales, marking a whopping 17% increase over last year. Now, that's not just growth—that's rocket fuel. Earnings per share rocketed up with...